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There is a large and rapidly growing body of literature on the importance of calcium and 
magnesium in biochemical and physiological processes. 
The objective of this study was to examine the relationship of serum lipid profile to the macro 
metals calcium and magnesium. Recent findings suggest that both calcium and magnesium 
play a vital role in many disease states notably in cardiovascular disease. Both calcium and 
magnesium intake is directly related to cardiovascular disorders.  
Magnesium acts as a mild calcium antagonist on vascular disease. Prospective studies 
involving both calcium and magnesium has given inconsistent results. 
This study done on 50 patients (25 males & females) attending cardiac clinic has shown good 
correlation between lipid profile and calcium and magnesium suggesting that along with the 
gold screening test of lipid profile in the diagnosis of cardio vascular disease (CVD), Calcium 
and magnesium should also be investigated to decide an appropriate supplementation 
therapy. 
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Introduction 
Cardiovascular disease is the number one killer in the 
world causing 4.5 million heart attacks and strokes each year. 
With the incidence of cardiovascular disease on a constant 
growth curve, test modalities that can provide specific 
inexpensive screening tools for CVD before the onset of 
symptoms is the proverbial “License to Print Money” and a 
large number of tests have been developed such as lipid 
profile, proteins, genetic markers and even tests for viral 
infections. 
Advances in the use of cardiac markers for evaluation of 
suspected myocardial infarction have been made in the past 5 
decades. Tests such as total cholesterol, triglycerides, LDH, 
AST, CK- Total which were popular in the 1950’s and 1960’s 
were replaced in the 1970’s and 1980’s by newer markers like 
HDL & LDL cholesterols, CK-MB, and Troponins. The new 
tests offered enhanced cardiac specificity, sensitivity & turn 
around time due to the use of advanced test kits and fully 
computerized automatic analyzers. 
The established risk factors that may precipitate 
cardiovascular disease include, Hypertension (inherited & 
acquired), ageing men, women after onset of menopause, 
Type II diabetes mellitus, Low HDL- cholesterol (inherited & 
acquired), High LDL – cholesterol (inherited & acquired), 
cigarette smokers, stress, sedentary life style, over weight by 
30% or more called obesity, smoking and family history 
accounts 25-79% of cases and Infection by pneumonia in 70-
80% of cases(1). 
300 predictors of heart disease have been identified so 
far. The recent findings include: Male baldness, increased hair 
in the crown area and elevated male hormone causes 3 fold 
increases in cardiac problems(2). 
Markers for cardiovascular disease 
Lipid profile 
It is the earliest marker, even today it is the first line 
marker done in almost all clinical laboratories. It is a group of 4 
tests, often ordered together determine the risk of coronary 
heart disease. The test that make up lipid profile are tests that 
have been shown to be good indicators of whether someone is 
likely to have a heart attack or stroke caused by blockage of 
blood vessels (Hardening of the arteries) 
The lipid profile includes, total cholesterol, HDL- 
cholesterol, LDL – cholesterol & triglycerides. Sometimes the 
report will include additional calculated values such as T 
cholesterol / HDL cholesterol ratio and VLDL. 
The lipid profile is used as a guide provider in deciding 
how a person at cardiac risk should be treated. The results of 
the lipid profile are considered along with other known risk 
factors of heart disease to develop a plan of treatment & follow 
up. Many develop cardiovascular disease in spite of normal 
serum cholesterol. About 50% of people who have heart attack 
have normal cholesterol. Hence lipid profile done in overnight 
fasting specimen is a traditional marker to predict cardiac 
arrest(3) 
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Diabetes and cardiovascular disease 
It has been established that CVD is the leading cause of 
diabetes related death. People with diabetes are two to four 
times more likely to develop cardiovascular disease due to a 
variety of risk factors, including: High blood pressure, Lipid 
disorders, High LDL (bad cholesterol), High triglycerides, Low 
HDL (good cholesterol), Smoking, Obesity, Lack of physical 
activity and poorly controlled blood sugars Another emerging 
risk factor is insulin resistance, a core metabolic dysfunction of 
type II diabetes(4). 
Understanding insulin resistance 
Insulin resistance is a condition in which the body doesn’t 
respond efficiently to the insulin it makes.  It affects about 60 
million people in the United States. One in four of them will 
develop type II diabetes when their body becomes unable to 
maintain normal insulin and glucose levels. 
Here’s a list of conditions typically found in people with 
type II diabetes and an explanation of how they contribute to a 
patient’s risk for developing CVD. 
• Obesity is a major risk factor for cardiovascular 
disease and has been strongly associated with insulin 
resistance. Insulin resistance may be a mechanism by which 
obesity leads to CVD. 
Weight loss can improve cardiovascular risk, decrease 
insulin concentration and its sensitivity. Obesity and insulin 
resistance also has been associated with other risk factors, 
such as      high blood pressure (5).  
• Physical inactivity is another modifiable major risk 
factor for insulin resistance and cardiovascular disease. 
Exercising and losing weight can prevent or delay the onset of 
type II diabetes, reduce blood pressure and help reduce the 
risk for heart attack and stroke. 
It’s likely that any type of physical activity – whether 
sports, household work, gardening or work related physical 
activity is similarly beneficial (6). 
• Hypertension (high blood pressure) has long been 
recognized as a major risk factor for cardiovascular disease. 
Studies report a positive association between hypertension 
and insulin resistance. When a person has both hypertension 
and diabetes, the risk for CVD doubles (7). 
• Dyslipidemia Atherogenic dyslipidemia, often 
called diabetic dyslipidemia in people with diabetes is a 
condition associated with insulin resistance, this type of 
dyslipidemia is characterized by high levels of triglycerides 
(hypertriglyceridemia), high levels of small LDL particles and 
low levels of HDL. This lipid triad often occurs in patients with 
premature coronary heart disease (8). 
 
Growing evidence suggests that all of the components of 
the lipid triad can contribute to the development of 
arteriosclerosis ( fatty buildups in artery walls) and can be 
considered a risk factor, Even though most patients with 
diabetes don’t have  marked elevation of LDL cholesterol, their 
levels are high enough to support the development of 
atherosclerosis (5). 
Other markers of cardiac disease which have been 
identified recently include lipoprotein A: Lp(a), the normal for 
which is <20mg/dL and level > 30mg/dL are considered risk.. 
Improper standardized techniques available are the major 
drawback for using this as routine cardiac marker (8). 
Other tests include: Apo-B, Homocysteine, often called 
the “Hidden cause of Heart attack”, Fibrinogen, High Sensitive 
CRP, D-Dimer, Co-enzyme Q10, Ascorbate & free radicals, 
Vitamin E deficiency . 
If the factors including cardio vascular disease are not 
controlled, Acute Myocardial Infarction (AMI)  will result and to 
detect AMI, a battery of tests are available. They include CK-
Total, CK-MB, Troponins I & Troponins –T(9). 
Magnesium 
There is increased interest in the role of magnesium ions 
in clinical medicine, nutrition and physiology. The 
characteristics of the binding of magnesium and calcium ions 
to various components, macromolecules and biological 
membranes have been described extensively. Magnesium 
affects many cellular functions including transport of potassium 
and calcium ions and modulates signal transduction, energy 
metabolism and cell proliferation (10). 
Magnesium is the most important major mineral which is 
used by our body. In order to function correctly and efficiently, 
our body needs nutrients. Over 300 bioreactions in vivo has 
been identified involving magnesium (11). 
Magnesium has a unique role inside cells in that it 
attaches to ATP, the energy molecules that do work in every 
living cell. Most enzymes which use ATP for energy need the 
Magnesium bound form. Studies have been carried out with 
the uptake of Magnesium using radioisotopes and by making 
measurements of the total amount of Magnesium. But nobody 
has been able to molecularly identity the proteins involved in 
the process (12). 
Magnesium is called ‘anti-stress mineral’ and it aids in 
relaxing nerves, relieving tension, assisting digestion, 
activating enzymes for metabolic pathways and modulating the 
electrical potential across all cell membranes. Magnesium is 
important in the production and transfer of energy, muscle 
contraction and relaxation. It also aids regularity, necessary to 
keep vertebrates in their proper position, induces restful sleep, 
purifies and paves body tissues and lowers fever. Chlorophyll 
and green vegetables contain large amounts of Magnesium.              
Adequate level of Magnesium is essential for the heart 
muscle. Those who die from heart attacks have very low 
Magnesium but high calcium level in their heart muscles. 
Patients with coronary heart disease who have been treated 
with large amounts Magnesium survive better than those with 
drug treatment (13).  
Magnesium is an important element for health and 
disease. It is the fourth most abundant intracellular cation, has 
been identified as a cofactor for more than 300 enzyme 
reactions involving energy metabolism, protein and nucleic 
acid synthesis. Approximately half of the total body magnesium 
is present in soft tissues, the other half in bone and less than 
1% in serum and red blood cells. The majority of experimental 
information comes from the measurements of Magnesium in 
serum and red blood cells. Little information is available in the 
literature about its equilibrium within the body pools. 
Magnesium is absorbed uniformly from the small intestine and 
the serum concentration is controlled by its excretion by the 
kidneys. The clinical laboratory evaluation of Magnesium 
status is primarily limited to the serum Magnesium level and 
24hr urinary excretion and percent retention following 
parenteral administration. However results for those do not 
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correlate with intracellular levels. There is no reliable test to 
determine intracellular total body Magnesium (14). 
Factors that deplete magnesium  
    Mental stress, physical stress, coffee, sugar, high 
sodium diet, alcohol, cola type sodas, tobacco ,high 
perspiration, medical drugs of all types, low thyroid, diabetes, 
chronic pain diuretics, a high carbohydrate diet and a high 
calcium diet. 
Deficiency Effects 
According to the nutrition almanac, magnesium deficiency 
can easily occur because magnesium is refined out of many 
foods during processing, cooking food removes the minerals, 
the oxalic acid in food like spinach and phytic acid found in 
cereals bind magnesium in the body (13). 
A deficiency can occur in people with diabetes, use of 
diuretics or digitalis preparation, the elderly pancreatitis, 
chronic alcoholism, kwashiorkor, pregnancy and cirrhosis. 
Magnesium deficiency is thought to be closely related to 
coronary heart disease including myocardialnecrosis. An 
inadequate supply leads to formation of clots in the heart and 
brain and may contribute to calcium deposit in the kidneys 
blood vessel (15). 
Magnesium deficiency may cause weakness, tremors, 
seizures, cardiac arrhythmias, hypokalemia and 
hypocalcaemia. Studies have documented that inadequate 
intake of Magnesium may lead to atherosclerosis, myocardial 
infarction, hypertension, cancer, kidney stones, premenstrual 
syndrome and psychiatric disorders. Hypomagnesaemia is 
primarily seen in acute and chronic renal failure, which is 
treated effectively by dialysis (16,17). 
Early signs of magnesium deficiency are loss of appetite, 
sleeplessness, weakness, nausea, vomiting, fatigue, muscle 
contractions and cramps, seizures, personality change, 
abnormal heart rhythms and coronary spasm. Due to 
magnesium deficiency people may develop headache, pain in 
the lower back: time goes by and body starts getting muscles 
cramps, then calcium muscle twitches and tics, high blood 
pressure, nervousness, have trouble sleeping and continually 
wake  up feeling  tired, spasms and finally chest pain (18). 
Hypomagnesemia 
In hypomagnesaemia, the level of magnesium in the 
blood is too low. The most common causes of 
hypomagnesaemia are decreased dietary intake (due to 
starvation) and decreased intestinal absorption 
(malabsorption). Hypomagnesaemia occurs frequently in 
people who have protracted diarrhea, increased excretion of 
Magnesium by the kidneys, high levels of aldosterone, anti 
diuretic hormone, or thyroid hormones. Diuretics, the antifungal 
drug amphotericin B, or the chemotherapy drug cisplatin can 
also cause hypomagnesemia (19,20,21). 
Magnesium is replaced when the deficiency causes 
symptoms or when the magnesium level is very low. 
Magnesium can be taken by mouth (usually as small amounts 
of magnesium hydroxide) or by injection into a muscle or vein.  
Hypermagnesemia 
In hypomagnesaemia, the level of magnesium in the 
blood is too high. Hypermagnesaemia usually develops only in 
people with kidney failure who are given magnesium salts or 
who take drugs that contain magnesium (such as some 
antacids or laxatives). 
Beneficial Effects 
Magnesium is necessary for the correct assimilation of 
calcium, potassium and the correct and efficient functioning of 
enzymes. Magnesium is nothing short of a miracle in its 
healing effect on a wide variety of diseases. Magnesium works 
together with hydrogen and antioxidants to keep our body 
structure soft.  Magnesium has a calming effect on the nervous 
system and is frequently used to promote good sleep. It can be 
used to calm irritated and over excited nerves.  Magnesium is 
vital in helping prevent heart attacks. It has also proved 
beneficial in the treatment of neuromuscular disorder, 
nervousness, tantrums, sensitivity to noise and hand tremor, 
reduce blood cholesterol and keep the arteries healthy, used 
for controlling conclusions in pregnant women, premature labor 
and epileptic seizures (22).  
ATP without magnesium is non functional and leads to 
cell death. All detoxification mechanisms have as the basis of 
the energy required to remove a toxicant the need for Mg-ATP 
to drive the process. There is nothing done in the body that 
does not use energy and without magnesium this energy can 
either be made or used.   
Calcium 
Calcium is the king of all alkalizing nutrients. The 
appropriate oxygen type of Calcium effectively douses acid the 
same way that water douses fire. It destroys oxygen robbing 
acid in the body fluid there by keeping the body alkaline so that 
it can prevent disease effortlessly and can reverse cancer. 
The American journal of nutrition states that virtually no 
major organ system escapes calcium influence. Dietary 
supplements of calcium along with vitamins prevent further 
spread of cancer (12,23,24). 
Calcium Deficiency 
Chronic calcium deficiency is associated with some forms 
of hypertension, prostate and colorectal cancer, some types of 
kidney stones, miscarriage, premenstrual problems, Joint and 
periodontal disease, sleep disturbances, mental depression, 
cardiovascular disease. Calcium levels are associated with 
arthritic or joint and vascular degeneration, calcification of soft 
tissues, hypertension, and stroke, mood and depressive 
disorders inhibits the cancer protective effects of vitamins 
(25,26). 
A weak heart rate means that calcium is deficient and the 
contraction phase is weak and short. This results in an 
increase in heart rate and also irregular heart rate because 
some contractions are missed entirely.  
Magnesium and Calcium 
Calcium and Magnesium are extremely important 
minerals that are often out of balance in persons with thyroid 
disease. Imbalance of these minerals can result in very rapid, 
low and irregular heart rate. Thyroid function itself is most likely 
controlled by the ratio of the minerals. 
Calcium is needed for muscle contraction   and 
magnesium  for muscular relaxation. The heart muscles are 
like all muscles. Calcium causes heart contraction; magnesium 
cause heart relaxation. 
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During hyperthyroidism, the magnesium is low and 
calcium is high. This measure is the result of other mineral 
imbalance (copper, zinc, iron, etc) but the effects on the heart 
rate are direct effects of a Ca/Mg and imbalance. 
To balance calcium and magnesium; a normal person 
needs a Ca/Mg ratio of about 2:1; a hyper needs more 
magnesium and a hypo needs more calcium, but these ratio 
need to be constantly adjusted to the normality (27). 
Never take calcium without magnesium. Calcium needs 
magnesium for it to assimilate. Intake of magnesium without 
any calcium will help to feel younger and more energetic. 
Calcium and magnesium belong to a group of 
parasympathetic elements that exhibit anti inflammatory or 
degenerative properties at higher amounts in contrast to 
potassium ions which are pro inflammatory when high. 
Dr. Linus Pauling, winner of two Nobel prizes once said 
“you can trace every sickness, every disease and every 
ailment to a mineral deficiency. Just as the human body needs 
adequate amounts of water and air for survival it also needs 
minerals or it will die”(28). 
Dr. Otto Warburg, also a winner of two Nobel prizes 
discovered in 1932 that cancer is the result of lack of oxygen in 
the body fluids which expels oxygen from the body stands to 
reason, therefore, that when you provide your body with the 
necessary minerals, you drive out the acid your body becomes 
more alkaline(29). 
Literature Review 
A link between Mg deficiency and sudden death is 
suggested by a substantial number of studies published over 
the past three decades. Data come from epidemiologic, 
autopsy, clinical, and animal studies. Sudden death is common 
in areas where community water supplies are Mg-deficient. 
Myocardial Mg content is low in people who die of sudden 
death. Cardiac arrhythmias and coronary artery vasospasm 
can be caused by Mg deficiency and Intravenous Mg reduces 
the risk of arrhythmia and death immediately after acute 
myocardial infarction (13,15,25,30).  
Because of these data, Mg supplementation has been 
proposed as a possible method of reducing the risk of sudden 
death. Suggested ways of supplementing Mg include public 
education to change dietary habits, addition of Mg to 
community water supplies, fortification of foods, and oral 
supplementation. Despite the substantial number of studies 
linking Mg deficiency with sudden death, no prospective 
studies have yet been investigated whether large-scale Mg 
supplementation is useful for the primary prevention of sudden 
death (31). 
Oral magnesium supplementation in  ischaemic heart 
disease patients with low erythrocyte magnesium levels led to 
significant increases of erythrocyte magnesium in these 
patients, and to an impressive decrease of anginal attacks and 
nitrate consumption, as well as to a lesser degree of ST 
segment depression on surface ECG obtained at exercise 
testing (32,33). 
In the examined geographic area a high prevalence of 
coronary artery disease was verified through the records of the 
Public Health Service, which documents the main causes of 
mortality in Tuscany, and through the hospitalization data and 
the services provided for ischemic heart disease at the local 
coronary care unit compared with the national 
average.Moreover, research was accomplished on physical 
and chemical properties of drinking water in the same area, 
and this revealed a very low total hardness due to the paucity 
of calcium and magnesium.It has been shown  that 
magnesium, hypertensive vascular diseases, atherogenesis, 
subcellular compartmentation of Ca and Mg and vascular 
contractility are all observed in Ca/Mg deficient populations 
(16,34). 
Abnormal dietary deficiency in Mg as well as 
abnormalities in Mg metabolism appear to play important roles 
as risk factors for ischemic heart disease and acute myocardial 
infarction, namely in hypertensive vascular disease, diabetic 
vascular disease, insulin resistance, atherosclerosis and 
vasospasm. Experimental, epidemiological as well as clinical 
evidence that supports a role for Mg in these risk factors are 
reviewed (35). 
Recent findings suggest that the ionized level of  Mg is an 
important determinant of vascular tone, contractility and 
reactivity.Low extracellular magnesium induces intracellular 
free Mg deficits, ischemia, depletion of high-energy 
phosphates and cardiac failure in intact working rat hearts. Low 
magnesium can result in marked reduction in oxygen and 
substrate delivery to the cardiac myocytes, probably as a result 
of coronary vasoconstriction (36). 
It is well established that clinically significant changes in a 
number of electrolytes occur in patients with congestive heart 
failure (CHF)(30). Magnesium ions are an essential 
requirement for many enzyme systems, and evidence is rapidly 
emerging that magnesium deficiency is a major risk factor for 
survival of CHF patients(37). In animal experiments, 
magnesium has been shown to be involved in several steps of 
the atherosclerotic process and, although in humans the 
situation is somewhat more complex, magnesium ions play an 
extremely important role in CHF and various cardiac 
arrhythmias (38). A number of drugs commonly used to treat 
CHF can significantly affect not only cellular magnesium ion 
homeostasis, but potassium as well. These include mercurial, 
thiazide, and loop diuretics (40). It has also been reported that 
hypomagnesemia is common in digitalis intoxication. In 
contrast, a number of agents have been shown to have either 
a magnesium-conserving effect (potassium-sparing diuretics) 
or not to affect magnesium ion balance (angiotensin-converting 
enzyme inhibitors). The clinical consequences of magnesium 
deficiency include the development of various cardiac 
arrhythmias, all of which respond well to magnesium treatment. 
Thus, it is more than apparent that magnesium ion 
homeostasis is of major importance in CHF. Future studies 
should address the complex role of magnesium ions in 
electrolyte imbalance, particularly in relation CVD (41). 
Materials and Methods 
After thoroughly going through the review of literature in 
which magnesium and calcium have a role in the regulation of 
cardiovascular disease and modulation in various physiological 
activities, we have decided to select a reasonable number of 
patients (both male and female, numbering 50 in the age group 
of 27 to 85 years attending the Master Health Checkup (MHC) 
at Apollo Speciality Hospital, Chennai for the evaluation of their 
routine health. We therefore made use of these patients for our 
study to establish a relationship between lipid profile and 
macro metals magnesium and calcium. As this study is mainly 
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to find out the association between lipid profile and the metals 
calcium and magnesium, we did not select established cardiac 
patients. 
Sample Collection 
As lipid profile will be affected due to non fasting, all 
samples were collected in the morning between 8 to 9am from 
the patients who had under gone over night fasting from 8pm 
till they reported to the blood collection centre at 8am the next 
day. 
All possible standard precautions were under taken while 
collecting blood samples. The use of sterile disposable needle 
and vaccutainer were employed for sample collection. All blood 
collections were done by qualified phlebotomists.. Correct 
procedure was followed at every step such as correct site for 
veins puncture and pressure used to transfer into vaccutainer. 
On the whole occurrence of haemolysis was prevented.  
Sample processing 
As soon as the sample was received it was allowed to clot 
at room temperature for 30 minutes. The tubes were gently 
tapped and then centrifuged for 10 minutes at 2500 rpm. After 
centrifugation, serum was transferred to clean glass tube using 
disposable pipettes. The samples were either analyzed 
immediately or preserved at <-15 °C until analysis.  
Biochemical assays 
 State of art fully automatic Olympus AU 640 Analyser 
was used to measure all the analytes undertaken in this study. 
Roche Diagnostics,GmBH,Manheim, Germany kits were used 
for the measurements of all analytes. Bio-Rad, USA accuracy 
controls were used to validate the accuracy of all analytes. 
Statistical analysis and presentation of results 
 A software, downloaded from the website 
www.easycalculation.com  was used to calculate correlation 
coefficient(r), t values and  the probability(p), all of which are 
presented in Tables IV  V and V1, for all patients, males and 
females Each Table contains the pair of analytes  compared, 
the correlation coefficient, t values and probability.
 
         Table I: Lipid Profile vs. divalent metals Ca & Mg for all patients 
S.NO AGE SEX TC HDL LDL TG TC/HDL Ca  Mg Ca/Mg  
1 68 M 234 48 154 115 4.9 9.8 2.15 4.56 
2 43 F 198 56 112 122 3.5 10.1 1.85 5.46 
3 72 M 185 50 143 178 3.7 8.9 1.75 5.09 
4 54 M 155 49 98 164 3.2 10 2.15 4.65 
5 60 M 212 53 162 165 4.0 9.7 1.95 4.97 
6 67 F 205 45 134 156 4.6 9.3 1.95 4.77 
7 48 F 278 49 89 136 5.7 10.4 2.1 4.95 
8 35 F 295 46 102 185 6.4 9.6 1.85 5.19 
9 40 M 184 51 138 125 3.6 9.9 2 4.95 
10 29 M 232 50 149 133 4.6 9.1 1.75 5.20 
11 55 F 198 43 93 164 4.6 9.8 2.3 4.26 
12 47 F 145 45 88 178 3.2 9.6 2.05 4.68 
13 37 F 250 44 138 175 5.7 9.3 1.75 5.31 
14 39 M 142 54 149 146 2.6 9.6 1.85 5.19 
15 42 M 208 56 93 110 3.7 10.1 2 5.05 
16 67 F 190 50 88 125 3.8 9.8 1.95 5.03 
17 51 M 198 47 138 188 4.2 9.9 2.05 4.83 
18 39 F 164 48 154 176 3.4 9.7 2.1 4.62 
19 38 M 146 58 110 168 2.5 8.9 1.65 5.39 
20 40 M 198 49 114 154 4.0 9.5 1.95 4.87 
21 47 F 205 42 87 210 4.9 9.9 2.05 4.83 
22 51 M 170 43 90 127 4.0 9.7 2.1 4.62 
23 46 M 184 50 108 152 3.7 8.9 1.75 5.09 
24 28 M 192 36 110 118 5.3 8.6 2.15 4.00 
25 27 M 175 54 138 102 3.2 9.4 1.85 5.08 
26 53 M 226 59 177 190 3.8 10.4 1.75 5.94 
27 54 F 185 49 114 157 3.8 9.8 2.04 4.80 
28 47 M 145 42 91 120 3.5 8.5 2.1 4.05 
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29 50 M 176 46 116 114 3.8 8.9 2 4.45 
30 33 M 207 62 130 220 3.3 10.3 1.68 6.13 
31 46 F 153 44 99 151 3.5 8.8 2.05 4.29 
32 32 M 196 51 138 157 3.8 10 1.97 5.08 
33 50 F 223 62 189 198 3.6 10.1 1.59 6.35 
34 85 F 163 35 97 144 4.7 8.8 2.27 3.88 
35 41 M 194 53 119 166 3.7 9.9 1.94 5.10 
36 25 F 151 42 96 112 3.6 8.9 2.07 4.30 
37 46 M 157 45 95 160 3.5 8.6 2.07 4.15 
38 48 M 210 69 161 166 3.0 10 1.45 6.90 
39 45 F 185 40 113 165 4.6 9.6 1.88 5.11 
40 86 F 210 35 148 210 6.0 9.8 1.52 6.45 
41 54 F 231 31 157 210 7.5 10.1 1.72 5.87 
42 50 M 144 43 89 151 3.3 8.8 2.24 3.93 
43 38 F 160 30 89 156 5.3 8.9 2.3 3.87 
44 27 F 183 45 113 120 4.1 9.6 1.95 4.92 
45 63 F 202 35 114 210 5.8 10.2 1.65 6.18 
46 67 M 181 39 124 188 4.6 9.8 2 4.90 
47 47 F 139 33 77 56 4.2 8.5 2.44 3.48 
48 63 F 228 65 157 142 3.5 10.2 1.65 6.18 
49 35 F 151 37 103 179 4.1 8.7 2.39 3.64 
50 57 F 186 48 136 172 3.9 9 1.85 4.86 
MEAN 48 - 191 47 120 156 4.2 9.5 2.0 4.9 
SD 13.9  - 34.3 8.6 27.3 33.4 1.0 0.6 0.2 0.7 
NORMAL  - -  < 200 >  40 < 130 < 150 < 4.5 8.4 - 10.2 1.6-2.3   
 
Table II: Lipid Profile vs. divalent metals Ca & Mg for Male patients 
S.NO AGE TC HDL LDL TG TC/HDL Ca  Mg Ca/Mg  
1 68 234 48 154 115 4.9 9.8 2.15 4.56 
2 72 185 50 143 178 3.7 8.9 1.75 5.09 
3 54 155 49 98 164 3.2 10 2.15 4.65 
4 60 212 53 162 165 4.0 9.7 1.95 4.97 
5 40 184 51 138 125 3.6 9.9 2 4.95 
6 29 232 50 149 133 4.6 9.1 1.75 5.20 
7 39 142 54 149 146 2.6 9.6 1.85 5.19 
8 42 208 56 93 110 3.7 10.1 2 5.05 
9 51 198 47 138 188 4.2 9.9 2.05 4.83 
10 38 146 58 110 168 2.5 8.9 1.65 5.39 
11 40 198 49 114 154 4.0 9.5 1.95 4.87 
12 51 170 43 90 127 4.0 9.7 2.1 4.62 
13 46 184 50 108 152 3.7 8.9 1.75 5.09 
14 28 192 36 110 118 5.3 8.6 2.15 4.00 
15 27 175 54 138 102 3.2 9.4 1.85 5.08 
16 53 226 59 177 190 3.8 10.4 1.75 5.94 
17 47 145 42 91 120 3.5 8.5 2.1 4.05 
18 50 176 46 116 114 3.8 8.9 2 4.45 
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19 33 207 62 130 220 3.3 10.3 1.68 6.13 
20 32 196 51 138 157 3.8 10 1.97 5.08 
21 41 194 53 119 166 3.7 9.9 1.94 5.10 
22 46 157 45 95 160 3.5 8.6 2.07 4.15 
23 48 210 69 161 166 3.0 10 1.45 6.90 
24 50 144 43 89 151 3.3 8.8 2.24 3.93 
25 67 181 39 124 188 4.6 9.8 2 4.90 
Mean 46 186 50 125 151 3.8 9.5 1.9 5.0 
SD 12 27 7 26 30 0.7 0.6 0.2 0.7 
 
 
Table III: Lipid Profile vs. divalent metals Ca & Mg for Female patients 
S.NO AGE TC HDL LDL TG TC/HDL Ca  Mg Ca/Mg  
1 43 198 56 112 122 3.5 10.1 1.85 5.46 
2 67 205 45 134 156 4.6 9.3 1.95 4.77 
3 48 278 49 89 136 5.7 10.4 2.1 4.95 
4 35 295 46 102 185 6.4 9.6 1.85 5.19 
5 55 198 43 93 164 4.6 9.8 2.3 4.26 
6 47 145 45 88 178 3.2 9.6 2.05 4.68 
7 37 250 44 138 175 5.7 9.3 1.75 5.31 
8 67 190 50 88 125 3.8 9.8 1.95 5.03 
9 39 164 48 154 176 3.4 9.7 2.1 4.62 
10 47 205 42 87 210 4.9 9.9 2.05 4.83 
11 54 185 49 114 157 3.8 9.8 2.04 4.80 
12 46 153 44 99 151 3.5 8.8 2.05 4.29 
13 50 223 62 189 198 3.6 10.1 1.59 6.35 
14 85 163 35 97 144 4.7 8.8 2.27 3.88 
15 25 151 42 96 112 3.6 8.9 2.07 4.30 
16 45 185 40 113 165 4.6 9.6 1.88 5.11 
17 86 210 35 148 210 6.0 9.8 1.52 6.45 
18 54 231 31 157 210 7.5 10.1 1.72 5.87 
19 38 160 30 89 156 5.3 8.9 2.3 3.87 
20 27 183 45 113 120 4.1 9.6 1.95 4.92 
21 63 202 35 114 210 5.8 10.2 1.65 6.18 
22 47 139 33 77 56 4.2 8.5 2.44 3.48 
23 63 228 65 157 142 3.5 10.2 1.65 6.18 
24 35 151 37 103 179 4.1 8.7 2.39 3.64 
25 57 186 48 136 172 3.9 9 1.85 4.86 
Mean 50 195 44 115 160 4.6 9.5 2.0 4.9 
SD 15 40 9 29 37 1.1 0.5 0.2 0.8 
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Table IV: statistical data: lipid profile, calcium and magnesium for 
All patients 
 
S.No 
 
 
PAIRS COMPARED 
 
CORRELATION 
COEFFICIENT 
 
‘t’ 
VALUE 
 
PROBABILITY 
(P) 
1 TC  Vs Ca 0.559971825 4.68 < 0.0001 
2 TC  Vs Mg 0.43689431 3.37 < 0.001 
3 TC  Vs Ca/Mg 0.535715527 4.4 < 0.0001 
4 HDL  Vs Ca 0.443937569 3.43 < 0.001 
5 HDL  Vs Mg 0.53649881 4.4 < 0.0001 
6 HDL  Vs Ca/Mg 0.569157303 4.8 < 0.0001 
7 LDL  Vs Ca 0.398875033 3.01 < 0.01 
8 LDL  Vs Mg 0.63573157 5.71 < 0.0001 
9 LDL  V s Ca/Mg 0.652301347 5.96 < 0.0001 
10 TG Vs Ca 0.379852436 2.8 < 0.01 
11 TG Vs Mg 0.43793585 3.39 < 0.001 
12 TG Vs Ca/Mg 0.493792774 3.93 < 0.0001 
 
Table V: Statistical data: lipid profile, calcium and magnesium 
Male patient 
 
S.No 
 
 
PAIRS COMPARED 
 
CORRELATION 
COEFFICIENT 
 
‘t’ 
VALUE 
 
PROBABILITY 
(P) 
1 TC  Vs Ca 0.5023 2.79 <0.01 
2 TC  Vs Ca/Mg 0.443857 2.38 <0.05 
3 HDL  Vs Ca 0.536452 3.05 <0.01 
4 HDL  Vs Mg -0.80058 6.41 <0.0001 
5 HDL  Vs Ca/Mg 0.898512 9.82 <0.0001 
6 LDL  Vs Ca 0.463544 2.51 <0.01 
7 LDL  Vs Mg -0.51908 2.91 <0.01 
8 LDL  V s Ca/Mg 0.614157 3.73 <0.001 
9 TG Vs Ca 0.364106 1.87 <0.05 
10 TG Vs Mg -0.39362 2.05 <0.05 
11 TG Vs Ca/Mg 0.483489 2.65 <0.01 
 
 
Table VI: Statistical data: lipid profile, calcium and magnesium 
Female patient 
 
S.No 
 
 
PAIRS COMPARED 
 
CORRELATION 
COEFFICIENT 
 
‘t’ 
VALUE 
 
PROBABILITY 
(P) 
1 TC  Vs Ca 0.623822 3.83 <0.01 
2 TC  Vs Mg 0.548953 3.15 <0.01 
3 TC  Vs Ca/Mg 0.601648 3.61 <0.001 
4 HDL  Vs Ca 0.470564 2.56 <0.01 
5 HDL  Vs Mg 0.379823 1.97 <0.05 
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6 HDL  Vs Ca/Mg 0.406488 2.13 <0.05 
7 LDL  Vs Ca 0.371931 1.91 <0.05 
8 LDL  Vs Mg -0.711992 4.97 <0.0001 
9 LDL  V s Ca/Mg 0.693011 4.61 <0.0001 
10 TG Vs Ca 0.395031 2.06 <0.05 
11 TG Vs Mg 0.497897 2.75 <0.01 
12 TG Vs Ca/Mg 0.514605 2.88 <0.01 
 
Results 
Table I shows the results for 6 analytes measured along 
with the two calculated parameters viz TC/HDL-C  & Ca to Mg 
ratios. 
This table gives the entire data for all the  patients  along 
with the mean and standard deviation for each group. The 
mean age of the  selected patient group is 48 years indicating 
the age at which cardiac problem may start developing. As the 
population selected were not cardiac related, the mean values  
for all the analytes studied lies  within the normal range used in 
this laboratory. As the sole aim of  this study is to find  the 
association between the  lipid profile and the metals Ca and 
Mg, grouping as cardiac and non – cardiac was not done. 
Tables II & III present similar data for Male and Female 
group 
Table IV presents the statistical data (r,t & p) for all the 
patients. This Table presents 12 pairs  of comparison. Almost 
all the lipid profile parameters shows very good correlation to 
both Calcium &  Magnesium and to Ca/Mg ratio (p < 0.001). 
Only LDL Vs Ca & Tg Vs Ca  gives a significant level of < 0.01. 
These observations indicate that lipid profile indeed shows 
strong association to both Calcium & Magnesium, indicating 
that these two metals are indeed related to cardiac function. 
Table V presents similar data for the 25 male patients. 
Only HDL Cholesterol shows a significance level of < 0.0001 to 
both Mg and to Ca/Mg ratio, indicating that it is the most 
important lipid as cardiac marker. However TC shows a 
significance of , <0.01 to Ca as well as Ca/Mg ratio. LDL also 
shows significance level of ,0.01 to both Ca & Mg as well as to 
its ratio. TG too shows some significance to both metals and its 
ratio. (<0.05, < 0.01) 
Table VI presents similar statistical parameters for the 25 
females included in this study. LDL cholesterol shows very 
good correation to Mg and Ca/Mg ratio(p < 0.0001), contrary to 
HDL cholesterol showing good correlation to these metals in 
the case of male patients. 
Almost all parameters of lipid profile shows good 
correlation, p ranges from       
(< 0.05 to < 0.0001), indicating that irrespective of sex, 
lipid profile are associated with the metals Ca & Mg. This study 
strongly suggests that measurement of Ca and Mg  should 
also be undertaken along with lipid profile for all patients 
suspected of having cardiac problem 
On the whole all the lipid profile para meters shows good 
associations to both metals and its ratio. 
 
Discussion 
Previous studies observed in the literature review have 
linked the role of calcium and magnesium in reducing cardiac 
related problems and magnesium supplementation studies 
have shown improvement in cardiac related complications 
(11,38,42). 
A recent study has linked cardio vascular disease pattern 
to both Ca and Mg and all cardiac patients are found to have 
low levels of Ca and Mg (43). In this study also we observed 
that the mean value for Ca and Mg were found to be around 
9.5 and 2.0, both values are at the lower end of the normal 
ranges, since the outcome of this study is also in consistency 
with previously established studies(44,45,46,47,48). All the 
lipid profile undertaken are found to have an association with 
the metals Ca and Mg and its ratio. 
Very few studies have been carried out linking post 
cardiac enzymes and the metals. Literature mentioning this 
aspect is very much lacking especially in the Indian scenario. 
As stated in some studies, myocardial magnesium content was 
low in people who died of sudden death due to cardiac arrest 
(34). 
Relationships have been established between lipid, 
Calcium & Magnesium in thyroid & CVD(49). Our study shows 
similar results to previous ones, but high light the importance of 
measuring the Ca & Mg in cardiac patients  
Summary 
• The main aim of this study was to find out the 
association between Lipid profile to the macrometals calcium 
and magnesium and their ratio. 
• 50 patients comprising of 25 males and 25 females 
were enrolled for this study 
•  Fasting blood samples were collected between 8 to 9 
am from all the patients. 
• Standard precautions and protocols were followed 
while collecting the sample and transporting to the laboratory. 
• The blood was allowed to clot for 30 minutes, 
centrifuged as per laboratory procedure, serum  transferred to 
another tube , analyzed immediately or preserved at < – 150c 
until analysis. 
•  Lipid profile and metals calcium and magnesium were 
measured   using Olympus AU 640 fully automatic analyzer 
using Roche Diagnostic kits. 
•  Established operating instructions and protocol were 
followed when carrying out the analysis. 
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•  Internationally validated Bio-Rad Accuracy   controls 
were included in each batch of analysis to assess the accuracy 
of the results obtained. 
•  Statistical analysis was carried out using a software 
downloaded from easycalculation.com to calculate r, t and p 
values using the analytes in pairs. 
•  The associations between the pairs were compared 
based on the p value obtained. 
• Very good association was found out between the lipid 
profile parameters and metals calcium and magnesium and its 
ratio. 
Conclusion 
• As the sole aim of this study was to find out  the 
association between lipid profile and the two important macro 
metals Calcium and Magnesium, we did not select established 
cardiac patients. 
• Good correlations were observed between lipid 
profile and the macro metals Calcium and Magnesium and its 
ratio for all the patients as well as in separate male and female 
groups. 
• Further studies are required to ascertain if Calcium 
and Magnesium supplementation will improve the pre and post 
cardiac biochemical markers to the normal level. 
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